Early Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic Leukemia Released
jarmoluk / Pixabay

Early Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic Leukemia Released

According to a story from BioPortfolio, the global biopharmaceutical company Celgene Corporation recently announced the release of early data from the dose-escalation portion of a Phase 1/2 clinical trial of lisocabtagene…

Continue Reading Early Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic Leukemia Released
International Experts Met with Goal to Improve Care for Chronic Myelomonocytic Leukemia Patients
https://pixabay.com/en/earth-planet-space-satellite-1913747/

International Experts Met with Goal to Improve Care for Chronic Myelomonocytic Leukemia Patients

Chronic myelomonocytic leukemia, or CMML, is a rare condition. However, it has similarities to myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). That being said, it still a unique diagnosis, and…

Continue Reading International Experts Met with Goal to Improve Care for Chronic Myelomonocytic Leukemia Patients

Presentations Demonstrate Promising Advances in Blood Cancers and Blood Disorders

According to a story from PR Newswire, presentations at the 60th annual American Society of Hematology Meeting and Exposition are highlighting the results of four large scale clinical trials that…

Continue Reading Presentations Demonstrate Promising Advances in Blood Cancers and Blood Disorders
Potential New Treatment for Huntington’s Disease Granted Orphan Drug Designation
Source: Pixabay.com

Potential New Treatment for Huntington’s Disease Granted Orphan Drug Designation

Huntington's Disease is a neurodegenerative condition caused by a genetic mutation. It results in progressive decline of motor skills. It also affects cognitive function. Patients experience decline for 15-20 years…

Continue Reading Potential New Treatment for Huntington’s Disease Granted Orphan Drug Designation

Potential New Treatment for Amyotrophic Lateral Sclerosis which Doesn’t Require Swallowing!

Amyotrophic lateral sclerosis (ALS) is a condition which affects the bodies nerve cells. It's neurodegenerative and progressive, causing the patient muscle weakness and muscle atrophy. It eventually results in paralysis.…

Continue Reading Potential New Treatment for Amyotrophic Lateral Sclerosis which Doesn’t Require Swallowing!
A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients
Source: Pixabay.com

A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients

Mantle cell lymphoma is caused by a genetic mutation which  produces cancerous white blood cells. Of course, these are the cells which fight infection in a normal body. Therefore in…

Continue Reading A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients

Experimental Gene Therapy for Type 1 Spinal Muscular Atrophy Gets Priority Review

According to a story from BioPortfolio, the drug developer Novartis recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational gene therapy AVXS-101, also known…

Continue Reading Experimental Gene Therapy for Type 1 Spinal Muscular Atrophy Gets Priority Review
Teen Overcomes Rare Disease That Causes Severe Shoulder Pain to Dance in the Nutcracker 
Source: Pixabay.com

Teen Overcomes Rare Disease That Causes Severe Shoulder Pain to Dance in the Nutcracker 

Behold the power of sheer will, determination, and tenacity! New York teen Hannea Milliman overcame the rare disorder Parsonage Turner Syndrome - which causes severe pain in the shoulder and arm -…

Continue Reading Teen Overcomes Rare Disease That Causes Severe Shoulder Pain to Dance in the Nutcracker 

Experimental Gene Therapy for Fanconi Anemia Earns Fast Track and Regenerative Medicine Advanced Therapy Designation

According to a story from BioPortfolio, the gene therapy company Rocket Pharmaceuticals has recently announced that the company's investigational gene therapy RP-L102 has earned both Fast Track and Regenerative Medicine…

Continue Reading Experimental Gene Therapy for Fanconi Anemia Earns Fast Track and Regenerative Medicine Advanced Therapy Designation